CA Stock MarketDetailed Quotes
GENX Genix Pharmaceuticals Corp
- 0.050
- -0.005-9.09%
15min DelayMarket Closed Nov 29 16:00 ET
2.96MMarket Cap-781P/E (TTM)
0.050High0.050Low1.00KVolume0.050Open0.055Pre Close50.00Turnover0.09052wk High0.00%Turnover Ratio59.22MShares0.01552wk Low-0.064EPS TTM1.68MFloat Cap1.050Historical HighLossP/E (Static)33.55MShs Float0.010Historical Low-0.07EPS LYR0.00%Amplitude--Dividend TTM-2.17P/B1Lot Size--Div YieldTTM
Genix Pharmaceuticals Corp Key Stats
Quarterly+Annual
YOY
| (Q3)Jul 31, 2024 | (Q2)Apr 30, 2024 | (Q1)Jan 31, 2024 | (FY)Oct 31, 2023 | (Q4)Oct 31, 2023 | (Q3)Jul 31, 2023 | (Q2)Apr 30, 2023 | (Q1)Jan 31, 2023 | (FY)Oct 31, 2022 | (Q4)Oct 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 13.07%-45.93K | -4.79%-58.5K | 17.30%-42.56K | -0.50%-220.67K | -31.41%-60.55K | 16.41%-52.83K | 30.00%-55.82K | -68.48%-51.46K | 48.73%-219.58K | -248.69%-46.08K |
| Net income from continuing operations | 49.93%-82.17K | 63.28%-85.94K | 73.99%-59.06K | -309.27%-4.4M | -1,374.99%-3.77M | 34.97%-164.1K | -2.86%-234.02K | 32.93%-227.04K | 35.01%-1.07M | 30.64%-255.62K |
| Operating gains losses | 115.72%1.1K | 53.10%6.11K | -35.83%-8.3K | -79.80%5.75K | -17.50%14.89K | -1,102.43%-7.02K | 149.78%3.99K | -175.01%-6.11K | --28.49K | --18.05K |
| Depreciation and amortization | -99.79%283 | -99.79%283 | -99.80%283 | -2.97%547.42K | -2.44%135.92K | -4.04%135.92K | -2.99%137.42K | -2.40%138.16K | 5.14%564.17K | -14.07%139.32K |
| Asset impairment expenditure | ---- | ---- | ---- | --3.46M | ---- | ---- | ---- | ---- | --0 | ---- |
| Remuneration paid in stock | ---- | ---- | ---- | -77.12%59.21K | ---- | ---- | ---- | ---- | -68.02%258.83K | -86.72%25.42K |
| Other non cashItems | 234.30%31.82K | 235.34%26.77K | 252.48%23.63K | 473.84%49.4K | 1,234.53%25.2K | 152.53%9.52K | 271.30%7.98K | 736.03%6.71K | 334.36%8.61K | --1.89K |
| Change In working capital | 111.18%3.04K | -119.84%-5.72K | -97.63%874 | 1,091.36%56.24K | -28.51%17.78K | -2,400.74%-27.16K | 171.45%28.81K | 238.84%36.82K | 95.42%-5.67K | 12,053.85%24.86K |
| -Change in receivables | -170.36%-1.21K | 88.42%-720 | -119.78%-1.58K | 229.78%15.09K | 210.06%11.6K | -68.43%1.71K | -52.15%-6.22K | 429.04%8K | -482.94%-11.63K | -238.87%-10.54K |
| -Change in inventory | -17.55%357 | -90.52%748 | -351.25%-1.9K | 107.33%12.21K | 101.88%3.12K | --433 | --7.89K | --757 | -3,343.35%-166.49K | ---166.49K |
| -Change in prepaid assets | 100.86%15.84K | 89.93%-730 | -13.57%-22.37K | 95.12%-173 | 29.79%18.89K | 317.40%7.89K | 61.16%-7.25K | -569.69%-19.7K | 87.54%-3.54K | 218.70%14.56K |
| -Change in payables and accrued expense | 67.86%-11.95K | -114.58%-5.01K | -44.03%26.73K | -83.46%29.11K | -108.45%-15.84K | -1,187.74%-37.19K | 295.77%34.38K | 424.70%47.76K | 288.17%175.99K | 4,096.57%187.34K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 13.07%-45.93K | -4.79%-58.5K | 17.30%-42.56K | -0.50%-220.67K | -31.41%-60.55K | 16.41%-52.83K | 30.00%-55.82K | -68.48%-51.46K | 48.73%-219.58K | -248.69%-46.08K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | -3.34K | 0 | |||||||
| Net intangibles purchas and sale | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---3.34K | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---3.34K | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 178.95%46.62K | 7.02%58.75K | -51.81%40.23K | 138.87%223.04K | 1,358,860.00%67.95K | -84.89%16.71K | 25.33%54.9K | 236.87%83.48K | 172.11%93.37K | 100.00%5 |
| Net issuance payments of debt | 178.95%46.62K | 7.02%58.75K | -71.73%40.23K | 89.99%281.88K | 9,876.69%67.95K | -84.98%16.71K | 25.33%54.9K | 2,472.05%142.32K | 1,159.75%148.37K | 95.04%-695 |
| Net other financing activities | ---- | ---- | ---- | -6.99%-58.84K | --0 | --0 | --0 | -6.99%-58.84K | 52.38%-54.99K | --700 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 178.95%46.62K | 7.02%58.75K | -51.81%40.23K | 138.87%223.04K | 1,358,860.00%67.95K | -84.89%16.71K | 25.33%54.9K | 236.87%83.48K | 172.11%93.37K | 100.00%5 |
| Net cash flow | ||||||||||
| Beginning cash position | -76.35%9.55K | -77.48%9.3K | 25.51%11.63K | -93.32%9.27K | -92.34%4.24K | 405.37%40.36K | -12.66%41.29K | -93.32%9.27K | -80.07%138.81K | -67.79%55.34K |
| Current changes in cash | 101.90%686 | 126.83%249 | -107.29%-2.33K | 101.82%2.36K | 116.05%7.39K | -176.28%-36.12K | 97.64%-928 | 134.98%32.02K | 76.78%-129.55K | -39.56%-46.08K |
| End cash Position | 141.49%10.23K | -76.35%9.55K | -77.48%9.3K | 25.51%11.63K | 25.51%11.63K | -92.34%4.24K | 405.37%40.36K | -12.66%41.29K | -93.32%9.27K | -93.32%9.27K |
| Free cash from | 13.07%-45.93K | -4.79%-58.5K | 17.30%-42.56K | 1.01%-220.67K | -31.41%-60.55K | 16.41%-52.83K | 32.81%-55.82K | -68.48%-51.46K | 47.95%-222.92K | -147.77%-46.08K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
% Chg
No Data